Translation of an STR-based biomarker into a clinically compatible SNP-based platform for loss of heterozygosity.
about
Barrett's oesophagus and oesophageal adenocarcinoma: time for a new synthesisEarly events during neoplastic progression in Barrett's esophagusThe gene-reduction effect of chromosomal losses detected in gastric cancers.Single nucleotide polymorphism (SNP)-based loss of heterozygosity (LOH) testing by real time PCR in patients suspect of myeloproliferative diseaseA comprehensive survey of clonal diversity measures in Barrett's esophagus as biomarkers of progression to esophageal adenocarcinoma.
P2860
Translation of an STR-based biomarker into a clinically compatible SNP-based platform for loss of heterozygosity.
description
2009 nî lūn-bûn
@nan
2009 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Translation of an STR-based bi ...... rm for loss of heterozygosity.
@ast
Translation of an STR-based bi ...... rm for loss of heterozygosity.
@en
type
label
Translation of an STR-based bi ...... rm for loss of heterozygosity.
@ast
Translation of an STR-based bi ...... rm for loss of heterozygosity.
@en
prefLabel
Translation of an STR-based bi ...... rm for loss of heterozygosity.
@ast
Translation of an STR-based bi ...... rm for loss of heterozygosity.
@en
P2093
P2860
P356
P1433
P1476
Translation of an STR-based bi ...... rm for loss of heterozygosity.
@en
P2093
Brian J Reid
Heather D Kissel
Patricia C Galipeau
Xiaohong Li
P2860
P304
P356
10.3233/CBM-2009-0618
P577
2009-01-01T00:00:00Z